InvestorsHub Logo
Followers 62
Posts 3932
Boards Moderated 0
Alias Born 12/21/2010

Re: None

Wednesday, 06/22/2016 10:14:38 AM

Wednesday, June 22, 2016 10:14:38 AM

Post# of 399476
For new investors who want to learn more about this company,Let play Connect the dots and then we gonna do some graph reading

First connect the dots
"The US Food and Drug Administration (FDA) today announced new class-wide safety labeling changes for immediate-release (IR) opioid pain medications, which make up about 90% of all opioid prescriptions"

IR = 90% market share from a$22Billion opioid market? WOW
lets see what else the FDA has to say

"Dr. Hertz [ph] made several statements regarding anti-abuse that this is the way of the future and she also indicated that as of today, they do not have an IR ADT yet. And to me that was a very good sign for Elite because to the best of my knowledge, we’re the only one in the queue at that one"

90% is awsome but even at 10 or 20% whe would have revenues close to $5 billion
Thats a lot for a 200mil otc company

And now the difference between TEVA's Vantrela "recently approved with ADF labeling" and elites soon to be approved SequestOX

As you can see, tevas vantrela drug liking curve is impressive, thats the reason it got approved by the FDA
But when you look at elites sequestox drug liking curve

Its even better, much better
So there is no reason this should not be approved within a few weeks
Soon elite will be the first in the 20 BILLION DOLLAR IR ADF OPIOID MARKET


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News